Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-25 @ 7:16 PM
NCT ID: NCT03391232
Description: None
Frequency Threshold: 1
Time Frame: up to 41 weeks
Study: NCT03391232
Study Brief: PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Single Dose of PolyPEPI1018 CRC Vaccine The subjects were treated with only one dose PolyPEPI1018 CRC vaccine. 0 None 1 5 2 5 View
Multiple Dose of PolyPEPI1018 CRC Vaccine The subjects received 2 or 3 doses PolyPEPI1018 CRC vaccine. 0 None 2 6 6 6 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
THROMBOEMBOLIC EVENT (Embolism) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (20.1) View
ABDOMINAL PAIN (Abdominal pain) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
BOWEL OBSTRUCTION (Intestinal obstruction) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
NON-INFECTIOUS ACUTE ENCEPHALITIS (Noninfective encephalitis) SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
INJECTION SITE REACTION-SOME SUBCUTANEOUS NODULARITY SYSTEMATIC_ASSESSMENT General disorders MedDRA (20.1) View
MUSCLE DISORDERS SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (20.1) View
NEUROLOGICAL DISRORDERS NEC SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View
ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (20.1) View
GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
GASTROINTESTINAL SIGNS AND SYMPTOMS SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
JOINT DISORDERS SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (20.1) View
EMBOLISM AND THROMBOSIS SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (20.1) View
GENERAL SYSTEM DISORDERS NEC SYSTEMATIC_ASSESSMENT General disorders MedDRA (20.1) View
EPIDERMAL AND DERMAL CONDITIONS SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.1) View
CENTRAL NERVOUS SYSTEM INFECTIONS AND INFLAMMATIONS SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View